|
?xml version="1.0" encoding="utf-8"?> <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <pre> 1. Error occurred: cannot get document summary PMID: 24835598
AÑO: 2014; IF: 2.844
|
24835598
|
Leal-Hernández M, Marín F. Use of antithrombotic therapy in patients with atrial fibrillation in primary care. Importance of INR control. Rev Esp Cardiol (Engl Ed). 2014 May;67(5):419. doi: 10.1016/j.rec.2014.02.003. PubMed PMID: 24774743.
AÑO: 2014
|
|
Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke. 2014 Mar;45(3):696-701. doi: 10.1161/STROKEAHA.113.003338. PubMed PMID: 24519407.
AÑO: 2014; IF: 5.761
|
|
de la Morena G, Caro C, Saura D, Marín F, Gimeno JR, González J, Oliva MJ, García-Navarro M, López-Cuenca A, Espinosa MD, Valdés M. Exercise eco-Doppler in hypertrophic cardiomyopathy patients. Determinant factors of exercise intolerance. Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):98-103. doi: 10.1016/j.rec.2012.06.011. PubMed PMID: 24775382.
AÑO: 2013; IF: 3.342
|
|
Gallego P, Roldán V, Marin F, Gálvez J, Valdés M, Vicente V, Lip GY. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med. 2014 Nov;127(11):1083-8. doi: 10.1016/j.amjmed.2014.05.023. PubMed PMID: 24858062.
AÑO: 2014; IF: 5.003
|